A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth
- PMID: 24411120
- PMCID: PMC3893713
- DOI: 10.1016/j.beth.2013.05.001
A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth
Abstract
The objective of this study was to extend the probability of treatment benefit method by adding treatment condition as a stratifying variable, and illustrate this extension of the methodology using the Child and Adolescent Anxiety Multimodal Study data. The probability of treatment benefit method produces a simple and practical way to predict individualized treatment benefit based on pretreatment patient characteristics. Two pretreatment patient characteristics were selected in the production of the probability of treatment benefit charts: baseline anxiety severity, measured by the Pediatric Anxiety Rating Scale, and treatment condition (cognitive-behavioral therapy, sertraline, their combination, and placebo). We produced two charts as exemplars which provide individualized and probabilistic information for treatment response and outcome to treatments for child anxiety. We discuss the implications of the use of the probability of treatment benefit method, particularly with regard to patient-centered outcomes and individualized decision-making in psychology and psychiatry.
Keywords: child/adolescent anxiety; evidence-based treatment; individualized treatment benefit; patient-centered decision-making; treatment response and outcome.
Copyright © 2013. Published by Elsevier Ltd.
References
-
- Achenbach T. Integrative guide for the 1991 CBCL/4-18, YSR, and TRF Profiles. Burlington: University of Vermont, Department of Psychiatry; 1991.
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th. ed. Washington, DC: Author; 2000. text revision.
Publication types
MeSH terms
Substances
Grants and funding
- U01 MH64092/MH/NIMH NIH HHS/United States
- U01 MH064107/MH/NIMH NIH HHS/United States
- U01 MH64003/MH/NIMH NIH HHS/United States
- U01 MH064092/MH/NIMH NIH HHS/United States
- U01 MH64107/MH/NIMH NIH HHS/United States
- U01 MH064089/MH/NIMH NIH HHS/United States
- U01 MH063747/MH/NIMH NIH HHS/United States
- U01MH63747/MH/NIMH NIH HHS/United States
- K24 MH096760/MH/NIMH NIH HHS/United States
- R25 MH080916/MH/NIMH NIH HHS/United States
- K01 MH093508/MH/NIMH NIH HHS/United States
- U01 MH64088/MH/NIMH NIH HHS/United States
- U01MH64003/MH/NIMH NIH HHS/United States
- U01 MH064003/MH/NIMH NIH HHS/United States
- K23 MH099179/MH/NIMH NIH HHS/United States
- U01 MH064088/MH/NIMH NIH HHS/United States
- K23 MH99179/MH/NIMH NIH HHS/United States
- K01 MH93508/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical